| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9308380 | Kidney International | 2005 | 7 Pages |
Abstract
Hemoglobin cycling is a common occurrence in rHuEPO-treated hemodialysis patients. It is most closely associated with frequent rHuEPO dose changes, hospitalization, and iron treatment practices.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Steven Fishbane, Jeffrey S. M.D.,